Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children’s oncology group report-Reference-Cited by-同舟云学术

Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children’s oncology group report

Published:2011-04-18 Issue:6 Volume:153 Page:758-763
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Shiramizu Bruce,Goldman Stanton,Kusao Ian,Agsalda Melissa,Lynch James,Smith Lynette,Harrison Lauren,Morris Erin,Gross Thomas G.,Sanger Warren,Perkins Sherrie,Cairo Mitchell S.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08681.x/fullpdf

Reference20 articles.

1. Screening for residual disease in pediatric Burkitt lymphoma using consensus primer pools;Agsalda;Advances in Hematology,2009

2. Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008;Bruggemann;Leukemia,2010

3. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents;Cairo;Blood,2007

4. Safety, efficacy and rituximab levels following chemoimmunotherapy (rituximab + FAB chemotherapy) in children and adolescents with mature B-cell non-Hodgkin lymphoma (B-NHL): a Children’s Oncology Group report;Cairo;Blood,2008

5. Safety, kinetics, and outcome following rituximab (R) in combination with FAB chemotherapy in children and adolescents (C+A) with stage III/IV (Group B) and BM+/CNS+ (Group C) mature B-NHL: a Children’s Oncology Group report;Cairo;Journal of Clinical Oncology,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma;Best Practice & Research Clinical Haematology;2023-03

2. Clinical Characteristics and Treatment Outcomes of Pediatric Patients with Non-Hodgkin Lymphoma in East Asia;Cancer Research and Treatment;2020-04-15

3. The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice;Frontiers in Oncology;2019-06-26

4. Lymphoma diagnostics: getting more from less;British Journal of Haematology;2019-02-19

5. Investigating the potential benefit of second biopsy of residual mass in pediatric mature B cell non-Hodgkin lymphoma;Pediatric Hematology and Oncology;2019-02-17